Pay in 4 interest-free payments of $5.62 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Healthcare System Navigation Canadian healthcare providers generally cannot prescribe or officially recommend BPC-157 given its unapproved status
We combine GLP-1 support with: Baseline and follow-up labs to monitor your progress Coaching around nutrition, movement, sleep, and stress Adjustments to your dosage and plan as your body changes Our goal is to help you lose weight in a healthy, controlled way , protect lean muscle as much as possible, and support long-term metabolic healthnot just short-term scale victories
Dual Mechanisms of Action: Appetite Suppression: Improved Glycemic Control: Fat Utilization: Sustainability and Adherence: Enhanced Control Over Hunger and Satiety Enhanced Weight Loss: Metabolic Benefits: Of course, there is no such thing as a free lunch, and nobody rides for free
Whilst these findings were encouraging, the study was relatively small and designed primarily to assess safety and feasibility rather than definitive efficacy
26, 2026: When Novo Nordisk filed suit against Hims & Hers in early February, the case immediately drew attention as a high-stakes patent fight over semaglutide and what it could mean for the broader multi-billion-dollar market for GLP-1 treatments
US$ 22.77
US$ 23.73
US$ 28.02
US$ 20.45
